Immune Deficiencies

1 protocols meet the specified criteria

OCR17838

Phase I/II Feasibility Study of busulfan, Fludarabine, and Thiotepa Conditioning Regimen for Allogeneic Hematopoietic Stem-Cell Transplantation (HSCT) for Children with Non-Malignant Disorders